Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
FGF21 contributes to metabolic improvements elicited by combination therapy with exenatide and pioglitazone in patients with type 2 diabetes.
Journal: American journal of physiology. Endocrinology and metabolism
Published: June 20, 2022
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.
Journal: The Journal of clinical investigation
Published: November 24, 2020
Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
Journal: International journal of obesity (2005)
Published: December 13, 2018
Eccentric exercise increases circulating fibroblast activation protein α but not bioactive fibroblast growth factor 21 in healthy humans.
Journal: Experimental physiology
Published: September 01, 2017
FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 02, 2017
Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Journal: Endocrinology
Published: February 23, 2016
Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1.
Journal: Cell reports
Published: January 29, 2015
Serum FGF21 levels are associated with brown adipose tissue activity in humans.
Journal: Scientific reports
Published: November 10, 2014
Teenager with shortness of breath and hypoxia.
Journal: The Journal of family practice
Published: July 26, 2014
Fibroblast growth factor (Fgf) 21 is a novel target gene of the aryl hydrocarbon receptor (AhR).
Journal: Toxicology and applied pharmacology
Published: January 24, 2014
Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones.
Journal: Molecular metabolism
Published: May 07, 2013
Last Updated: 09/26/2026